- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT06704971
Évaluer le déclin cognitif à la maison
Évaluation automatique des symptômes neuropsychiatriques à domicile prédictif de la santé mentale et des troubles cognitifs à l'aide de technologies d'intelligence ambiante non intrusives
Neuropsychiatric symptoms (NPS) refer to a range of mental and emotional issues that can be observed through how patients move, perform daily tasks, and express feelings on their faces. In this study, the investigators want to find ways to accurately and unobtrusively track these symptoms in people's homes over time. Our goals are to note when these symptoms happen, predict potential problems, and gather clear data to help doctors make accurate diagnoses.
To do this, the investigators will first collect information from participants who have in-home sensors. the investigators will then use special computer programs that can recognize everyday activities and identify features that connect to scores from the Mild Behavioral Impairment Checklist (MBI-C). These scores will be compared to a questionnaire (NPIQ) filled out by caregivers or family members, along with any relevant information from doctors about the patients' symptoms. The investigators aim to see how these features can help differentiate between types of NPS, such as mood changes and agitation.
Finally, the investigators will create a dashboard for doctors that summarizes the patterns of these symptoms in patients, making it easier to monitor and manage their mental health.
Aperçu de l'étude
Statut
Description détaillée
What the investigators would need from participants:
- Collect the participants' own data of daily activities from a room in participants home such as the participant's living room via a small camera the investigators provide for no less than 7 days and up to 30 days. The participant will have full control over the camera to turn on and off.
- The participant and a loved one will regularly answer short surveys asking about the participant's mood and daily functioning.
- At the end of agreed observation period, return the memory card of the participant's collected data from the camera in person or pre-paid FedEx envelope.
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
California
-
Palo Alto, California, États-Unis, 94304
- Clinical Excellence Research Center
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
Older Adults - 65+
La description
Inclusion criteria:
- Age 65+ years old
- Any age and ethnicity.
- With or without, or at risk of mild to moderate dementia and healthy controls.
- Availability of a study partner (informant) who has contact with the patient at least once a week (this can also be the surrogate/LAR but does not necessarily have to be)
Exclusion criteria:
- Those with severe mobility impairments
- participants in non-home settings (skilled nursing facilities, etc.).
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Modèles d'observation: OTHER
- Perspectives temporelles: OTHER
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
develop a personalized and clinically interpretable NPS assessment system
Délai: 2 year
|
Assessing NPS relies primarily on clinician observation & interviews with caregivers, usually within brief & infrequent clinical visits. Precise assessment and monitoring methods would incorporate objective, patient- & caregiver-friendly, real-time tools and provide reliable & frequently captured data. We aim to create a system that can monitoring individual and subsyndromes of NPS; and detect early changes in NPS by automatically quantifying & detecting relevant behavioral abnormalities based on both intra- & inter-individual comparisons. Our approach is a video sensor, information processing, & alert system that utilizes in-home cameras & ambient sensors with video features that can recognize & track behaviors securely, pre-defines domains involved in a behavior; personalizes the results by assessing the individual's behavioral norms and the home environment; and analyzes, learns, and provides explainable items from different modalities of data: time, location, video, and audio. |
2 year
|
|
NPS Clinical Dashboard
Délai: 1 year
|
Overall, the investigators envision the clinical dashboard as a transformative tool that delivers clear and comprehensive data on each individual. Therefore enhancing the quality of diagnosis of NPS for individuals, leading to better patient interventions and more effective long term management strategies. |
1 year
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
generate Data and support for a large-scale study or clinical trial within the context of an R01.
Délai: 2 years
|
the ultimate goal of this project is to generate feasibility data and infrastructure for a large-scale study with a possible clinical trial within the context of an R01. In parallel, to translate the technology into clinical practice, we will work with the Stanford Office of Technology Licensing (OTL) to productize the outcomes. |
2 years
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Ehsan Adeli, PhD, Stanford University
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
- Manifestations neurologiques
- Maladies du cerveau
- Maladies du système nerveux central
- Maladies du système nerveux
- Les troubles mentaux
- Manifestations neurocomportementales
- Troubles neurocognitifs
- Troubles cognitifs
- Tauopathies
- Maladies neurodégénératives
- Conditions pathologiques, signes et symptômes
- Signes et symptômes
- Dysfonctionnement cognitif
- Maladie d'Alzheimer
- Démence
- Troubles de la mémoire
Autres numéros d'identification d'étude
- 68794
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .